emory center for aids research

Emory Training Program in Translational Research to End the HIV Epidemic

Emory Training Program in Translational Research to End the HIV Epidemic is now accepting applications to fill postdoctoral slots for 2024. The program will offer a continuous rolling application and deadlines will vary depending on the intended start date.

Please click here for additional details.

    About the Program

    In 2021, the Emory CFAR launched the Emory Training Program in HIV Translational Research to End the Epidemic T32 program. The program is fully administratively and scientifically integrated into the Emory CFAR to capitalize on the spectrum of ongoing HIV investigation at our institution. The T32 program focuses on translational HIV science at the epicenter of the United States HIV epidemic in the South and was built around research activities in three major focus areas including 1) Laboratory-based basic science, vaccine, and cure research, 2) Patient-centered clinical research, and 3) Public health and implementation science. Trainees will gain expertise to conduct cutting-edge HIV research through hands-on experience and formal didactics with emphasis on educating trainees in the broader context of HIV research across the translational continuum. There are five post-doctoral fellow slots for candidates with a PhD, MD, or MD/PhD degree and one pre-doctoral slot for an Emory PhD student.

    Program Goals

    1. To provide two years of support to five post-doctoral fellows as well as an opportunity for one pre-doctoral student with an emphasis on historically under-represented minority trainees to conduct cutting-edge HIV research through hands-on experience and formal didactics with emphasis on educating trainees in the broader context of HIV research across the translational continuum.
    2. To encompass research activities in each of the NIH HIV/AIDS research priorities to reduce the incidence of HIV, develop next generation HIV therapeutics, conduct research towards an HIV cure, and address HIV associated co-morbidities, co-infections and complications; but, more importantly, our program also exposes trainees to cross-cutting areas of HIV research and team science to accelerate the translation of discovery into improved health outcomes.

    Program Focus Areas and Mentors

    Program Directors

    Colleen Kelley, MD, MPH

    Program Director for Patient-Centered HIV Clinical Research

    Ann Chahroudi, MD, PhD

    Co-Program Director for HIV Basic Science

    Patrick Sullivan, DVM, PhD

    Co-Program Director for Public Health and Implementation Science Research

    Program Staff

    Deaunna Thomas

    Program Coordinator

    Elizabeth LaScala

    Program Financial Analyst

    Meet our T32 Trainees

    Amalia Aldredge, MD

    Post-doctoral Trainee
    Mentor: Anandi Sheth, MD
    Co-Mentor: Cecile Lahiri, MD, MS
    Start Date: July 1, 2022
    Department: Medicine- Infectious Disease
    Primary Area of HIV Research: Patient-centered Clinical Research
    Research Project: Sex-specific HIV outcomes: the role of low-level viremia

    Michael Curtis, PhD

    Post-doctoral Trainee
    Mentor: Sophia Hussen, MD, MPH
    Start Date: July 1, 2022
    Department: Global Health
    Primary Area of HIV Research: Public Health and Implementation Science
    Research Project: Exploring Associations Between Discrimination, Traumatic Stress, And Substance Use Among Young Black Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV

    Danielle Giovenco, PhD

    Post-doctoral Trainee
    Mentor: Patrick Sullivan, DVM, PhD
    Co-Mentor: Don Operario, PhD
    Start Date: July 31, 2022
    Department: Epidemiology
    Primary Area of HIV Research: Public Health and Implementation Science
    Research Project: K application: Preventing disruptions in progress towards ending HIV/AIDS: Lessons from the COVID-19 pandemic

    Sydney Bergstresser, BS

    Pre-doctoral Trainee
    Mentor: Deanna Kulpa, PhD
    Start Date: July 31, 2023
    Department: Immunology and Molecular Pathogenesis
    Primary Area of HIV Research: Laboratory-based Science, Vaccine, and Cure Research
    Research Project: Bcl-2 antagonism to reduce the reservoir in ART treated SIV-infected Rhesus macaques

    Wendy Fujita, MD

    Post-doctoral Trainee
    Mentor: Anandi Sheth, MD
    Co-Mentor: Hannah Cooper, ScD
    Start Date: July 1, 2022
    Department: Medicine- Infectious Disease
    Primary Area of HIV Research: Patient-centered Clinical Research
    Research Project: Substance Use Treatment Utilization Among Women with and at risk for HIV

    Ryan Slack, PhD

    Post-doctoral Trainee
    Mentor: Stefan Sarafianos, PhD
    Start Date: January 1, 2022
    Department: Pediatrics
    Primary Area of HIV Research: Laboratory-based Science, Vaccine, and Cure Research
    Research Project: Interactions between HIV-1 Reverse Transcriptase and human APOBEC3G

    Contact 

    To contact the Emory HIV T32 Program, reach out to Deaunna Thomas.

    Deaunna Thomas
    Program Coordinator
    Email: deaunna.thomas@emory.edu

    Contact Us

    Center for AIDS Research at Emory University
    1518 Clifton Rd, NE
    R. Randall Rollins Building, R558
    Mailstop: 1518-002-5CC
    Atlanta, GA 30322-4201
    404.727.2924  |  cfaradmin@emory.edu